Grifols SA
GRFS9.280USD
+0.090+0.98%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
2.39BMarktkapitalisierung
15.27KGV TTM
mehr Informationen über Grifols SA Unternehmen
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
Grifols SA Informationen
BörsenkürzelGRFS
Name des UnternehmensGrifols SA
IPO-datumMay 17, 2006
CEOAbia (Jose Ignacio)
Anzahl der mitarbeiter23833
WertpapierartDepository Receipt
GeschäftsjahresendeMay 17
AddresseParque Empresarial Can Sant Joan
StadtSANT CUGAT DEL VALLES
BörseNASDAQ OMX - NASDAQ BASIC
LandSpain
Postleitzahl08174
Telefon34935710000
Websitehttps://www.grifols.com/
BörsenkürzelGRFS
IPO-datumMay 17, 2006
CEOAbia (Jose Ignacio)
Führungskräfte von Grifols SA
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Tomas Daga Gelabert
Mr. Tomas Daga Gelabert
Other External Director
Other External Director
--
--
Mr. Raimon Grifols Roura
Mr. Raimon Grifols Roura
Vice Chairman of the Board, Proprietary Director
Vice Chairman of the Board, Proprietary Director
--
--
Ms. Nuria Martin Barnes
Ms. Nuria Martin Barnes
Non-Member Secretary of the Board of Directors
Non-Member Secretary of the Board of Directors
--
--
Mr. Ignacio Ramal Subira
Mr. Ignacio Ramal Subira
Chief Internal Audit & Enterprise Risk Management
Chief Internal Audit & Enterprise Risk Management
--
--
Mr. David Ian Bell
Mr. David Ian Bell
Chief Corporate Affairs and Legal Officer
Chief Corporate Affairs and Legal Officer
--
--
Mr. Inigo Sanchez-Asiain Mardones
Mr. Inigo Sanchez-Asiain Mardones
Independent Director
Independent Director
--
--
Mr. Victor Grifols Deu
Mr. Victor Grifols Deu
Proprietary Director
Proprietary Director
--
--
Ms. Enriqueta Felip Font
Ms. Enriqueta Felip Font
Independent Director
Independent Director
--
--
Ms. Maria Teresa Rione Llano
Ms. Maria Teresa Rione Llano
Chief Communications Officer
Chief Communications Officer
--
--
Mr. Daniel Fleta Coit
Mr. Daniel Fleta Coit
Chief Industrial Services Officer
Chief Industrial Services Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Tomas Daga Gelabert
Mr. Tomas Daga Gelabert
Other External Director
Other External Director
--
--
Mr. Raimon Grifols Roura
Mr. Raimon Grifols Roura
Vice Chairman of the Board, Proprietary Director
Vice Chairman of the Board, Proprietary Director
--
--
Ms. Nuria Martin Barnes
Ms. Nuria Martin Barnes
Non-Member Secretary of the Board of Directors
Non-Member Secretary of the Board of Directors
--
--
Mr. Ignacio Ramal Subira
Mr. Ignacio Ramal Subira
Chief Internal Audit & Enterprise Risk Management
Chief Internal Audit & Enterprise Risk Management
--
--
Mr. David Ian Bell
Mr. David Ian Bell
Chief Corporate Affairs and Legal Officer
Chief Corporate Affairs and Legal Officer
--
--
Mr. Inigo Sanchez-Asiain Mardones
Mr. Inigo Sanchez-Asiain Mardones
Independent Director
Independent Director
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q2
FY2021
FY2020
FY2019
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States/Canada
1.25B
57.30%
Rest of the World
469.41M
21.53%
European Union
461.58M
21.17%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Sat, Jan 31
Aktualisiert: Sat, Jan 31
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Brandes Investment Partners, L.P.
11.31%
Capital World Investors
8.91%
Permian Investment Partners, LP
6.78%
Black Creek Investment Management, Inc.
3.90%
Millennium Management LLC
2.69%
Andere
66.41%
Aktionäre
Aktionäre
Anteil
Brandes Investment Partners, L.P.
11.31%
Capital World Investors
8.91%
Permian Investment Partners, LP
6.78%
Black Creek Investment Management, Inc.
3.90%
Millennium Management LLC
2.69%
Andere
66.41%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
29.46%
Hedge Fund
12.70%
Investment Advisor/Hedge Fund
6.36%
Research Firm
5.71%
Pension Fund
1.01%
Sovereign Wealth Fund
0.75%
Bank and Trust
0.14%
Family Office
0.03%
Andere
43.84%
Institutionelle Beteiligung
Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
346
145.03M
56.34%
-19.52M
2025Q3
327
150.82M
58.58%
-12.54M
2025Q2
305
150.67M
58.35%
-8.81M
2025Q1
318
151.56M
58.69%
-8.09M
2024Q4
317
145.36M
56.29%
-25.01M
2024Q3
302
144.07M
55.96%
-19.66M
2024Q2
298
148.36M
57.63%
-6.71M
2024Q1
295
140.29M
54.61%
+6.03M
2023Q4
303
126.55M
49.26%
-7.36M
2023Q3
316
123.59M
48.19%
-7.60M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Brandes Investment Partners, L.P.
29.12M
11.31%
+1.08M
+3.85%
Sep 30, 2025
Capital World Investors
22.93M
8.91%
+1.27M
+5.88%
Sep 30, 2025
Permian Investment Partners, LP
17.45M
6.78%
-1.18M
-6.31%
Sep 30, 2025
Black Creek Investment Management, Inc.
10.05M
3.9%
-2.52M
-20.08%
Sep 30, 2025
Millennium Management LLC
6.94M
2.69%
-2.73M
-28.24%
Sep 30, 2025
BofA Global Research (US)
3.99M
1.55%
+975.13K
+32.31%
Sep 30, 2025
Janus Henderson Investors
3.45M
1.34%
+250.17K
+7.82%
Sep 30, 2025
BMO Capital Markets (US)
2.90M
1.13%
+2.90M
--
Sep 30, 2025
Arrowstreet Capital, Limited Partnership
2.80M
1.09%
+2.22M
+383.69%
Sep 30, 2025
Harris Associates L.P.
2.73M
1.06%
-392.80K
-12.57%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
AdvisorShares Dorsey Wright ADR ETF
2.19%
Brandes International ETF
1.85%
Brandes US Small-Mid Cap Value ETF
1.85%
Capital Group International Core Equity ETF
0.18%
ProShares Ultra Nasdaq Biotechnology
0.13%
Invesco Nasdaq Biotechnology ETF
0.11%
iShares Biotechnology ETF
0.1%
ActivePassive International Equity ETF
0.08%
State Street SPDR S&P Kensho New Econ Comp ETF
0.03%
SPDR Portfolio Developed World ex-US ETF
0.01%
Mehr Anzeigen
AdvisorShares Dorsey Wright ADR ETF
Anteil2.19%
Brandes International ETF
Anteil1.85%
Brandes US Small-Mid Cap Value ETF
Anteil1.85%
Capital Group International Core Equity ETF
Anteil0.18%
ProShares Ultra Nasdaq Biotechnology
Anteil0.13%
Invesco Nasdaq Biotechnology ETF
Anteil0.11%
iShares Biotechnology ETF
Anteil0.1%
ActivePassive International Equity ETF
Anteil0.08%
State Street SPDR S&P Kensho New Econ Comp ETF
Anteil0.03%
SPDR Portfolio Developed World ex-US ETF
Anteil0.01%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
307.84M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Jul 30, 2025
GRFS.NB Final Cash Dividend of gross USD 0.175789 paid on Aug 20, 2025 going ex on Aug 12, 2025
Aug 12, 2025
Aug 20, 2025
Aug 12, 2025
May 25, 2021
GRFS.NB Interim Cash Dividend of gross USD 0.456586 paid on Jun 14, 2021 going ex on Jun 03, 2021
Jun 04, 2021
Jun 14, 2021
Jun 03, 2021
Oct 23, 2020
GRFS.NB Interim Cash Dividend of gross USD 0.201439 paid on Nov 09, 2020 going ex on Oct 30, 2020
Nov 02, 2020
Nov 09, 2020
Oct 30, 2020
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
